Literature DB >> 25093402

Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer.

Workalemahu M Berhanu1, Artëm E Masunov.   

Abstract

Amyloid fibrils are highly ordered protein aggregates associated with many diseases affecting millions of people worldwide. Polyphenols such as Curcumin, Exifone, and Myricetin exhibit modest inhibition toward fibril formation of tau peptide which is associated with Alzheimer's disease. However, the molecular mechanisms of this inhibition remain elusive. We investigated the binding of three polyphenol molecules to the protofibrils of an amyloidogenic fragment VQIVYK of tau peptide by molecular dynamics simulations in explicit solvent. We find that polyphenols induce conformational changes in the oligomer aggregate. These changes disrupt the amyloid H bonding, perturbing the aggregate. While the structural evolution of the control oligomer with no ligand is limited to the twisting of the β-sheets without their disassembly, the presence of polyphenol molecule pushes the β-sheets apart, and leads to a loosely packed structure where two of four β-sheets dissociate in each of the three cases considered here. The H-bonding capacity of polyphenols is responsible for the observed behavior. The calculated binding free energies and its individual components enabled better understanding of the binding. Results indicated that the contribution from Van der Waals interactions is more significant than electrostatic contribution to the binding. The findings from this study are expected to assist in the development of aggregation inhibitors. Significant binding between polyphenols and aggregate oligomer identified in our simulations confirms the previous experimental observations in which polyphenols refold the tau peptide without forming covalent bonds.

Entities:  

Keywords:  Curcumin; Exifone; MM-PBSA; Myricetin; aggregation inhibitors; amyloid fibril; binding free energy; hydrogen bond; molecular dynamic simulation; polyphenols

Mesh:

Substances:

Year:  2014        PMID: 25093402     DOI: 10.1080/07391102.2014.951689

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  11 in total

Review 1.  The structure and phase of tau: from monomer to amyloid filament.

Authors:  Yifan Zeng; Jing Yang; Bailing Zhang; Meng Gao; Zhengding Su; Yongqi Huang
Journal:  Cell Mol Life Sci       Date:  2020-10-19       Impact factor: 9.261

Review 2.  Natural product-based amyloid inhibitors.

Authors:  Paul Velander; Ling Wu; Frances Henderson; Shijun Zhang; David R Bevan; Bin Xu
Journal:  Biochem Pharmacol       Date:  2017-04-06       Impact factor: 5.858

Review 3.  The Structure Biology of Tau and Clue for Aggregation Inhibitor Design.

Authors:  Dan Wang; Xianlong Huang; Lu Yan; Luoqi Zhou; Chang Yan; Jinhu Wu; Zhengding Su; Yongqi Huang
Journal:  Protein J       Date:  2021-08-17       Impact factor: 2.371

4.  A theoretical study of polymorphism in VQIVYK fibrils.

Authors:  Jaehoon Yang; Mithila V Agnihotri; Carol J Huseby; Jeff Kuret; Sherwin J Singer
Journal:  Biophys J       Date:  2021-02-09       Impact factor: 4.033

Review 5.  Recent Developments and Applications of the MMPBSA Method.

Authors:  Changhao Wang; D'Artagnan Greene; Li Xiao; Ruxi Qi; Ray Luo
Journal:  Front Mol Biosci       Date:  2018-01-10

6.  Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.

Authors:  V Guru KrishnaKumar; Ashim Paul; Ehud Gazit; Daniel Segal
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

7.  The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.

Authors:  Sahar Andarzi Gargari; Abolfazl Barzegar; Alireza Tarinejad
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

8.  Anthraquinone Derivative Reduces Tau Oligomer Progression by Inhibiting Cysteine-Cysteine Interaction.

Authors:  Carlos Areche; Francisca Zapata; Mathias González; Esteban Díaz; Rubén Montecinos; Marcos Hernández; Francisco Melo; Alberto Cornejo
Journal:  ChemistryOpen       Date:  2019-02-08       Impact factor: 2.911

9.  Inhibition of Protein Aggregation by Several Antioxidants.

Authors:  Samra Hasanbašić; Alma Jahić; Selma Berbić; Magda Tušek Žnidarič; Eva Žerovnik
Journal:  Oxid Med Cell Longev       Date:  2018-03-25       Impact factor: 6.543

10.  Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.

Authors:  Akhil Kumar; Ashish Tiwari; Ashok Sharma
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.